|
1
|
Zhong Q, Sun Q, Xu GF, Fan XQ, Xu YY, Liu
F, Song SY, Peng CY and Wang L: Differential analysis of lymph node
metastasis in histological mixed-type early gastric carcinoma in
the mucosa and submucosa. World J Gastroenterol. 24:87–95. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanahashi T, Yoshida K and Yamaguchi K:
Current status and future perspective of the chemotherapy for
gastric cancer. Nihon Shokakibyo Gakkai Zasshi. 115:500–506.
2018.(In Japanese). PubMed/NCBI
|
|
3
|
Li T, Gao X, Han L, Yu J and Li H:
Identification of hub genes with prognostic values in gastric
cancer by bioinformatics analysis. World J Surg Oncol. 16:1142018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dreznik A, Purim O, Idelevich E, Kundel Y,
Sulkes J, Sulkes A and Brenner B: Gastric cancer: Biology and
clinical manifestations in Israel. J Surg Oncol. 105:316–322. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sasaki T: Discussion for gastric cancer
treatment guidelines in Japan. Nihon Rinsho. 61:13–18. 2003.(In
Japanese).
|
|
6
|
Kim H, Kim H, Kim SY, Kim TY, Lee KW, Baek
SK, Kim TY, Ryu MH, Nam BH and Zang DY: Second-line chemotherapy
versus supportive cancertreatment in advanced gastric cancer: A
meta-analysis. Ann Oncol. 24:2850–2854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cong P, Zhang G, Chen Z, Chen Y and Zhang
L: lncRNApred: Classification of long non-coding RNAs and
protein-coding transcripts by the ensemble algorithm with a new
hybrid feature. PLoS One. 11:e01545672016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao MX, Jiang YP, Tang YL and Liang XH:
The crosstalk between lncRNA and microRNA in cancer metastasis:
Orchestrating the epithelial-mesenchymal plasticity. Oncotarget.
8:12472–12483. 2015. View Article : Google Scholar
|
|
9
|
Chen D, Sun Q, Cheng X, Zhang L, Song W,
Zhou D, Lin J and Wang W: Genome-wide analysis of long noncoding
RNA (lncRNA) expression in colorectal cancer tissues from patients
with liver metastasis. Cancer Med. 5:1629–1639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: lncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1 and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Liu X, Zhang H, Sun L, Zhou Y, Jin
H, Zhang H, Zhang H, Liu J, Guo H, et al: Hypoxia-inducible
lncRNA-AK058003 promotes gastric cancer metastasis by targeting
γ-synuclein. Neoplasia. 16:1094–1106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang L, Li J, Zhao H, Hu J, Ping Y, Li F,
Lan Y, Xu C, Xiao Y and Li X: Identifying the crosstalk of
dysfunctional pathways mediated by lncRNAs in breast cancer
subtypes. Mol Biosyst. 12:711–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu F, Li H and Hu C: LIFR-AS1 modulates
Sufu to inhibit cell proliferation and migration by miR-197-3p in
breast cancer. Biosci Rep. 39:BSR201805512019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu K, Yao H, Wen Y, Zhao H, Zhou N, Lei S
and Xiong L: Functional role of a long non-coding RNA
LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to
pohotodynamic therapy. Biochim Biophys Acta Mol Basis Dis.
1864:2871–2880. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaihara N and Harris C: MicroRNA
involvement in human cancers. Clin Chem. 59:1811–1812. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matamala N, Vargas MT, González-Cámpora R,
Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G,
Yanowsky K, Calvete-Candenas J, et al: Tumor MicroRNA expression
profiling identifies circulating MicroRNAs for Early breast cancer
detection. Clin Chem. 61:1098–1096. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Nangia-Makker P, Farhana L and
Majumdar A: A novel mechanism of lncRNA and miRNA interaction:
CCAT2 regulates miR-145 expression by suppressing its maturation
process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao NB, He YF, Li XQ, Wang K and Wang RL:
The role of miRNA and lncRNA in gastric cancer. Oncotarget.
8:81572–81582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mikkelsen LH, Andersen MK, Andreasen S,
Larsen AC, Tan Q, Toft PB, Wadt K and Heegaard S: Global microRNA
profiling of metastatic conjunctival melanoma. Melanoma Res.
29:465–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kalhori MR, Arefian E, Fallah Atanaki F,
Kavousi K and Soleimani M: miR-548× and miR-4698 controlled cell
proliferation by affecting the PI3K/AKT signaling pathway in
glioblastoma cell lines. Sci Rep. 10:15582020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seibold S, Rudroff C, Weber M, Galle J,
Wanner C and Marx M: Identification of a new tumor suppressor gene
located at chromosome 8p21.3-22. FASEB J. 17:1180–1182. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kara M, Kaplan M, Bozgeyik I, Ozcan O,
Celik OI, Bozgeyik E and Yumrutas O: MTUS1 tumor suppressor and its
miRNA regulators in fibroadenoma and breast cancer. Gene.
587:173–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ozcan O, Kara M, Yumrutas O, Bozgeyik E,
Bozgeyik I and Celik OI: MTUS1 and its targeting miRNAs in
colorectal carcinoma: Significant associations. Tumour Biol.
37:6637–6645. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao J, Chen JX, Zhu YP, Zhou LY, Shu QA
and Chen LW: Reduced expression of MTUS1 mRNA is correlated with
poor prognosis in bladder cancer. Oncol Lett. 4:113–118. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak K and Schmittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G,
Zhao Q, Wu D, Gong W, Du M, et al: lncRNA MT1JP functions as a
ceRNA in regulating FBXW7 through competitively binding to
miR-92a-3p in gastric cancer. Mol Cancer. 17:872018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu F, Gao H, Liu K, Gao B, Ren H, Li Z and
Liu F: The lncRNA ZEB2-AS1 is upregulated in gastric cancer and
affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Onco Targets Ther. 12:657–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiao Y, Pan J, Geng Q and Wang G: lncRNA
MALAT1 increases the stemness of gastric cancer cells via enhancing
SOX2 mRNA stability. FEBS Open Bio. 9:1212–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Frey HA, Stout MJ, Pearson LN, Tuuli MG,
Cahill AG, Strauss JF III, Gomez LM, Parry S, Allsworth JE and
Macones GA: Genetic variation associated with preterm birth in
African-American women. Am J Obstet Gynecol. 215:235.e1–e8. 2016.
View Article : Google Scholar
|
|
32
|
Aissani B, Zhang K and Wiener H: Genetic
determinants of uterine fibroid size in the multiethnic NIEHS
uterine fibroid study. Int J Mol Epidemiol Genet. 6:9–19.
2015.PubMed/NCBI
|
|
33
|
Yao K, Wang Q, Jia J and Zhao H: A
competing endogenous RNA network identifies novel mRNA, miRNA and
lncRNA markers for the prognosis of diabetic pancreatic cancer.
Tumor Biol. 39:10104283177078822017. View Article : Google Scholar
|
|
34
|
Matboli M, Shafei A and Ali M, El-Din
Ahmed TS, Naser M, Abdel-Rahman T, Anber N and Ali M: Role of
extracellular lncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal
cancer. Arch Physiol Biochem. 1–7. 2019.doi:
10.1080/13813455.2019.1650070 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin Z, Zhou Z, Guo H, He Y, Pang X, Zhang
X, Liu Y, Ao X, Li P and Wang J: Long noncoding RNA gastric
cancer-related lncRNA1 mediates gastric malignancy through
miRNA-885-3p and cyclin-dependent kinase 4. Cell Death Dis.
9:6072018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma L, Zhou Y, Luo X, Gao H, Deng X and
Jiang Y: Long non-coding RNA XIST promotes cell growth and invasion
through regulating miR-497/MACC1 axis in gastric cancer.
Oncotarget. 8:4125–4135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen Z, Tang W, Guo J and Sun S:
miR-483-5p plays a protective role in chronic obstructive pulmonary
disease. Int J Mol Med. 40:193–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu J, Ma L, Wang Z, Wang L, Liu C, Chen R
and Zhang J: MicroRNA expression profile of gastric cancer stem
cells in the MKN-45 cancer cell line. Acta Biochim Biophys Sin
(Shanghai). 46:92–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Di Benedetto M, Bièche I, Deshayes F,
Vacher S, Nouet S, Collura V, Seitz I, Louis S, Pineau P,
Amsellem-Ouazana D, et al: Structural organization and expression
of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a
family of angiotensin II AT2 receptor-interacting proteins, ATIP.
Gene. 380:127–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zuern C, Heimrich J, Kaufmann R, Richter
KK, Settmacher U, Wanner C, Galle J and Seibold S: Down-regulation
of MTUS1 in human colon tumors. Oncol Rep. 23:183–189.
2010.PubMed/NCBI
|
|
41
|
Louis SN, Chow L, Rezmann L, Krezel MA,
Catt KJ, Tikellis C, Frauman AG and Louis WJ: Expression and
function of ATIP/MTUS1 in human prostate cancer cell lines.
Prostate. 70:1563–1574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li X, Liu H, Yu T, Dong Z, Tang L and Sun
X: Loss of MTUS1 in gastric cancer promotes tumor growth and
metastasis. Neoplasma. 61:128–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang X, Liu G, Ding L, Jiang T, Shao S,
Gao Y and Lu Y: HOXA3 promotes tumor growth of human colon cancer
through activating EGFR/Ras/Raf/MEK/ERK signaling pathway. J Cell
Biochem. 119:2864–2874. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hu G, Zhang J, Xu F, Deng H, Zhang W, Kang
S and Liang W: SLP-2 inhibits cisplatin-induced apoptosis through
MEK/ERK signaling and mitochondrial apoptosis pathway in cervical
cancer cells. Cancer Sci. 109:1357–1368. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fu X, Feng J, Zeng D, Ding Y, Yu C and
Yang B: PAK4 confers cisplatin resistance in gastric cancer cells
via PI3K/Akt- and MEK/ERK-dependent pathways. Biosci Rep.
34:e000942014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lin Z, Zhang C, Zhang M, Xu D, Fang Y,
Zhou Z, Chen X, Qin N and Zhang X: Targeting Cadherin-17
Inactivates Ras/Raf/MEK/ERK signaling and inhibits cell
proliferation in gastric cancer. PLoS One. 9:e852962014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhuang R, Zhang X, Lu D, Wang J, Zhuo J,
Wei X, Ling Q, Xie H, Zheng S and Xu X: lncRNA DRHC inhibits
proliferation and invasion in hepatocellular carcinoma via
c-Myb-regulated MEK/ERK signaling. Mol Carcinog. 58:366–375. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Y, Gu J, Lin X, Yan W, Yang W and Wu
G: lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling
pathway. Oncol Lett. 15:5865–5870. 2018.PubMed/NCBI
|
|
49
|
Sur S and Agrawal DK: Phosphatases and
kinases regulating CDC25 activity in the cell cycle: Clinical
implications of CDC25 overexpression and potential treatment
strategies. Mol Cell Biochem. 416:33–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang R, He G, Nelman-Gonzalez M, Ashorn
CL, Gallick GE, Stukenberg PT, Kirschner MW and Kuang J: Regulation
of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell.
128:1119–1132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Peyregne VP, Kar S, Ham SW, Wang M, Wang Z
and Carr BI: Novel hydroxyl naphthoquinones with potent Cdc25
antagonizing and growth inhibitory properties. Mol Cancer Ther.
4:595–602. 2005. View Article : Google Scholar : PubMed/NCBI
|
